Citations

Clear

382 citation(s) found for "Li, Man".

Sex hormones in alcohol consumption: a systematic review of evidence
Erol, Almıla , Ho, Ada Man‐Choi , Winham, Stacey J. , Karpyak, Victor M. , Ho, Ada M-C , Winham, Stacey J , Karpyak, Victor

Mayo Clinic

Addiction Biology | December 27, 2017 | Volume: 24 | Issue: 2 | Pages: 157-169

10.1111/adb.12589 | PMID 29280252 Get It

AbstractSex hormones play an important role in establishing sex‐distinctive brain structural and functional variations that could contribute to the sex differences in alcohol consumption behavior. Here, we systematically reviewed articles that studied sex hormone impacts on alcohol consumption and alcohol use disorder (AUD). An extensive literature search conducted in MEDLINE, PubMed, Scopus and CINAHL databases identified 776 articles, which were then evaluated for pre‐specified criteria for relevance and quality assurance. A total of 50 articles, including 19 human studies and 31 animal studies, were selected for this review. Existing evidence supports the association of increased testosterone level and increased risk for alcohol use and AUD in males but results are inconclusive in females. In contrast, the evidence supports the association of increased estrogen level and increased alcohol use in females, with mixed findings reported in males. Much less is known about the impact of progestins on alcohol use and misuse in human subjects. Future observational and experimental studies conducted in both sexes with a comprehensive hormone panel are needed to elucidate the impact of the interplay between various sex hormone levels during various developmental stages on alcohol use‐related phenotypes and AUD.
Effects of epinephrine on cardiovascular and metabolic responses to leg exercise in man
Marshall, Robert J. , Shepherd, John T.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 18 | Issue: 6 | Pages: 1118-1122

10.1152/jappl.1963.18.6.1118 | PMID 14080730 Get It

In studies on six experienced subjects lying supine, cardiac output and oxygen content of femoral venous blood were measured with the subject at rest, during the increase in muscle blood flow caused by intravenous infusion of epinephrine, during mild leg exercise, and during identical exercise combined with an infusion. The oxygen content of the blood from the exercising limb was much higher (average, 50%) during an infusion than when no infusion was given (average, 32%). The mean increase in cardiac output during the combined maneuver (8.2 liters/min) almost equaled the sum of the increases during the separate infusion (3.7 liters) and during exercise (4.7 liters). All individual studies showed approximately this same result. Thus, the additional blood supplied to the leg muscles by the infusion did not appear to be used for metabolic purposes during exercise. cardiac output; muscle blood flow Submitted on March 22, 1963
Correlation of hemodynamic events during infusion of epinephrine in man
Allwood, M. J., Keck, E. W., Marshall, Robert J. , Shepherd, John T.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 17 | Issue: 1 | Pages: 71-74

10.1152/jappl.1962.17.1.71 | PMID 13860643 Get It

Changes in cardiac output, stroke volume, and systemic blood pressure have been correlated with changes in muscle blood flow during the periods of initial transient and subsequent sustamed vasodilatation during intravenous infusion of epinephrine. In the initial phase blood pressure decreased slightly; forearm blood flow increased by 308%, cardiac output by 50%, and stroke volume by 10%. During the sustained phase the systolic blood pressure increased; corresponding increases for the other measurements were 87, 47, and 25%, respectively. The lack of correlation between these changes in cardiac output and forearm blood flow suggests that in the transient phase vasodilatation does not occur simultaneously in all muscle groups. Stroke volume makes a greater contribution to the increased output during the sustained phase. Submitted on May 29, 1961
Formation of Peripheral Pulse Contour in Man
Remington, J. W., Wood, Earl H.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 9 | Issue: 3 | Pages: 433-442

10.1152/jappl.1956.9.3.433 | PMID 13376469 Get It

PHYSIOLOGIC STUDIES ON THE MOTOR ACTIVITIES OF THE STOMACH AND BOWEL IN MAN
Alvarez, Walter C.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 24, 2017 | Volume: 88 | Issue: 4 | Pages: 650-662

10.1152/ajplegacy.1929.88.4.650 Get It

THE RENAL EXCRETION OF SUCROSE, XYLOSE, UREA AND INORGANIC SULPHATES IN NORMAL MAN: COMPARISON OF SIMULTANEOUS CLEARANCES
Keith, Norman M., Power, Marschelle H., Peterson, Ruth D.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 24, 2017 | Volume: 108 | Issue: 1 | Pages: 221-228

10.1152/ajplegacy.1934.108.1.221 Get It

Thoracic-Aorta Flow in Man
Grace, Joseph B., Fox, Irwin J., Crowley, William P., Wood, Earl H., Crowley, William P.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 11 | Issue: 3 | Pages: 405-418

10.1152/jappl.1957.11.3.405 | PMID 13480951 Get It

STUDIES ON THE INTESTINAL MUSCLE OF MAN
Ascanio, Hugo, Alvarez, Walter C.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 24, 2017 | Volume: 90 | Issue: 3 | Pages: 607-610

10.1152/ajplegacy.1929.90.3.607 Get It

Rate of loss of radioiron from mouse and man
Bonnet, John D., Orvis, Alan L., Hagedorn, Albert B., Owen, Charles A.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 21, 2017 | Volume: 198 | Issue: 4 | Pages: 784-786

10.1152/ajplegacy.1960.198.4.784 | PMID 13802571 Get It

Forty-two male and female mice, 8 weeks old, were given radioiron (Fe59) in doses of 0.006–0.1 µc, containing 0.013–0.17 µg of iron, by intraperitoneal or intravenous routes. Assays of the radioactivity of the whole body revealed an initial rapid loss of Fe59 (15–20%) lasting about 6 days. Thereafter the Fe59 left the mice at a steady rate of 0.39%/day (half-life 180 days). One 34-year-old normal man was given 10.6 µc of Fe59, containing 8.2 µg of iron, intravenously. Based on counts from the entire body, the biologic rate of loss of the Fe59 was about 0.14%/day (half-life 500 days), and there was little or no initial loss such as occurred in the mouse. The Fe59 in the circulating erythrocytes was essentially unchanged for the first 3 months. It then fell to a new level of about 90% of the previous one; the mid-point of the fall was about 120 days after the administration of the radioiron. The difference in the rates of loss of radioiron from mice and man seems to be related primarily to the life span of the circulating red cells.